CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...

CVS Health CVS continues to enjoy the strength of its diversified businesses. Third-quarter 2025 revenues hit a record $103 billion, up 8% year over year, with all segments contributing to growth. The ...

The largest contract paid CVS $200 million from 2020 through 2023, the period when McKee became governor and first campaigned against Foulkes.

Eli Lilly (LLY) is exiting CVS Health’s (CVS) drug benefit plan for its employees after the managed care giant decided to ...

Trividia Health, Inc., announced today that it's TRUE METRIX(R) Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...

Retailers’ grand plans to enter the primary care market have so far been unsuccessful. But CVS Health believes it can succeed where others have stumbled – and Houston is serving as a testing ground.

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. While competitors are struggling, cutting guidance, and looking for ways to mitigate the ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best health ...

Currently, CVS Health CVS and UnitedHealth Group UNH are two major vertically integrated behemoths in the U.S. healthcare market and key constituents of the S&P 500 index. Both companies have ...

CVS Caremark commercial members receive access to accurate and confident blood glucose testing Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are ...

Trividia Health, Inc., announced today that it’s TRUE METRIX ® Self-Monitoring Blood Glucose Systems are now preferred for ...